CXCR4 and COVID-19: Notably, further studies should explore the levels of growth and angiogenic factors such as VEGF, FGF‐2, CXCL12, and CXCR4 in COVID‐19 patients to determine the magnitude of vascular injury after SARS‐CoV‐2 infection.